1. Home
  2. VBIX vs PULM Comparison

VBIX vs PULM Comparison

Compare VBIX & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VBIX

Viewbix Inc.

N/A

Current Price

$1.06

Market Cap

11.5M

Sector

Technology

ML Signal

N/A

Logo Pulmatrix Inc.

PULM

Pulmatrix Inc.

HOLD

Current Price

$2.22

Market Cap

13.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VBIX
PULM
Founded
N/A
2003
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.5M
13.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VBIX
PULM
Price
$1.06
$2.22
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
138.7K
31.1K
Earning Date
03-24-2026
10-16-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,056,000.00
$3,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$134.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.96
$2.19
52 Week High
$9.80
$10.40

Technical Indicators

Market Signals
Indicator
VBIX
PULM
Relative Strength Index (RSI) 36.15 25.13
Support Level $1.05 $2.19
Resistance Level $1.18 $2.44
Average True Range (ATR) 0.13 0.38
MACD 0.03 -0.16
Stochastic Oscillator 28.42 2.57

Price Performance

Historical Comparison
VBIX
PULM

About VBIX Viewbix Inc.

ViewBix Inc operates in the field of digital advertising. Along with its subsidiaries, the company performs two main activities that are reported as separate operating segments: the search segment and the digital content segment. Maximum revenue is generated from the digital content segment, which is engaged in the creation and editing of content, in different languages, for different target audiences, to generate revenues from advertising platforms, including Google, Facebook, Yahoo, and Apple, by utilizing such content to obtain internet user traffic for its customers. The search segment develops various technological software solutions, which perform automation, optimization, and monetization of internet campaigns, to obtain and route internet user traffic to its customers.

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

Share on Social Networks: